Enhanced cytotoxicity of bisantrene when combined with venetoclax, panobinostat, decitabine and olaparib in acute myeloid leukemia cells

Benigno C. Valdez, Bin Yuan, David Murray, Yago Nieto, Uday Popat, Borje S. Andersson

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Enhanced cytotoxicity of bisantrene when combined with venetoclax, panobinostat, decitabine and olaparib in acute myeloid leukemia cells'. Together they form a unique fingerprint.

Medicine & Life Sciences